 KBL Merger Corp. IV is set to finalize the acquisition of 180 Life Sciences Corp. during Q4 2020 180 Life Sciences Corp. has several ongoing programs at different stages of development, with the leading candidate in Phase 2b3, helping mitigate the risks involved with its drug development The merger with 180 Life Sciences will enable ... Continue reading KBL Merger Corp. IV NASDAQ: KBLM Fulfilling IPO Goal Through Merger With 180 Life Sciences Corp. 